We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
+14.24%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.41%
AUM
$13B
AUM Growth
+$1.27B
Cap. Flow
+$54.9M
Cap. Flow %
0.42%
Top 10 Hldgs %
32.37%
Holding
3,201
New
230
Increased
637
Reduced
880
Closed
186

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$21.3M
2
MSFT icon
Microsoft
MSFT
+$18M
3
NVDA icon
NVIDIA
NVDA
+$13.4M
4
COF icon
Capital One
COF
+$8.78M
5
OKTA icon
Okta
OKTA
+$7.29M

Sector Composition

Rank Sector Weight
1 Technology 32.4%
2 Financials 13.84%
3 Consumer Discretionary 11.07%
4 Industrials 9.43%
5 Healthcare 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRM icon
3001
Vroom Inc
VRM
$51.2M
$1K ﹤0.01%
+37
New +$1.13K
TVGN icon
3002
Tevogen Inc. Common Stock
TVGN
$27.1M
$1K ﹤0.01%
15
CRML icon
3003
Critical Metals Corp
CRML
$1.02B
$1K ﹤0.01%
253
LPA
3004
Logistic Properties of the Americas
LPA
$90.7M
$1K ﹤0.01%
+108
New +$764
SVCO
3005
Silvaco Group
SVCO
$247M
$1K ﹤0.01%
207
ACTU
3006
Actuate Therapeutics
ACTU
$24.2M
$1K ﹤0.01%
+201
New +$1.76K
SBC
3007
SBC Medical Group
SBC
$315M
$1K ﹤0.01%
+193
New +$763
CIRC
3008
Circle8 Group
CIRC
$63M
$1K ﹤0.01%
+368
New +$1.11K
ABOS icon
3009
Acumen Pharmaceuticals
ABOS
$175M
-1,451
Closed -$2K
ACHV icon
3010
Achieve Life Sciences
ACHV
$684M
-1,192
Closed -$3K
ACRV icon
3011
Acrivon Therapeutics
ACRV
$74.5M
-378
Closed -$1K
ADVM
3012
DELISTED
Adverum Biotechnologies
ADVM
-720
Closed -$3K
AGEN
3013
Agenus
AGEN
$291M
-675
Closed -$1K
AKA icon
3014
a.k.a. Brands
AKA
$120M
-22
Closed
AKYA
3015
DELISTED
Akoya BioSciences
AKYA
-465
Closed -$1K
ALXO icon
3016
ALX Oncology
ALXO
$285M
-897
Closed -$1K
AMPY icon
3017
Amplify Energy
AMPY
$172M
-1,238
Closed -$5K
AMTX icon
3018
Aemetis
AMTX
$119M
-1,254
Closed -$2K
APLT
3019
DELISTED
Applied Therapeutics
APLT
-3,326
Closed -$2K
ATNM icon
3020
Actinium Pharmaceuticals
ATNM
$24.3M
-877
Closed -$1K
ATOS icon
3021
Atossa Therapeutics
ATOS
$23.7M
-292
Closed -$3K
JBIO
3022
Jade Biosciences
JBIO
$1.32B
$0 ﹤0.01%
9
-1
-10% -$34
BAER icon
3023
Bridger Aerospace
BAER
$81.2M
-310
Closed
BDTX icon
3024
Black Diamond Therapeutics
BDTX
$114M
-1,285
Closed -$2K
BLNK icon
3025
Blink Charging
BLNK
$85.6M
-3,320
Closed -$3K

Similar funds

Amalgamated Bank's Q2 2025 Portfolio in Review

As of Q2 2025, Amalgamated Bank held 3,201 positions worth $13B, up 11% from $11.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Amalgamated Bank's Q2 2025 filing shows 230 new, 637 increased, 880 reduced and 186 closed positions. Its largest new stake was Flutter Entertainment: 13,384 shares worth $3.83M. The largest sale was Discover Financial Services, an estimated $8.3M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Amalgamated Bank's largest Q2 2025 buy was Flutter Entertainment: 13,384 shares worth $3.83M.
  • Amalgamated Bank added most to Apple in Q2 2025, an estimated $21.3M increase.
  • Amalgamated Bank's biggest Q2 2025 reduction was Alphabet (Google) Class A, cutting an estimated $7.86M.
  • Amalgamated Bank fully exited Discover Financial Services in Q2 2025, selling an estimated $8.3M.
  • Amalgamated Bank's ten largest holdings make up 32% of its $13B portfolio in Q2 2025.
  • Amalgamated Bank opened 230 new positions and closed 186 in Q2 2025.
  • Amalgamated Bank's portfolio value rose 11% quarter-over-quarter to $13B.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.